Strom B L, Abrutyn E, Berlin J A, Kinman J L, Feldman R S, Stolley P D, Levison M E, Korzeniowski O M, Kaye D
University of Pennsylvania School of Medicine, Veterans Affairs Medical Center, Philadelphia 19104-6021, USA.
Ann Intern Med. 1998 Nov 15;129(10):761-9. doi: 10.7326/0003-4819-129-10-199811150-00002.
Although antibiotic prophylaxis against infective endocarditis is recommended, the true risk factors for infective endocarditis are unclear.
To quantitate the risk for endocarditis from dental treatment and cardiac abnormalities.
Population-based, case-control study.
54 hospitals in the Philadelphia area.
Persons with community-acquired infective endocarditis not associated with intravenous drug use were compared with community residents, matched by age, sex, and neighborhood of residence.
Information on demographic characteristics, host risk factors, and dental treatment was obtained from structured telephone interviews, dental records, and medical records.
During the preceding 3 months, dental treatment was no more frequent among case-patients than controls (adjusted odds ratio, 0.8 [95% CI, 0.4 to 1.5]). Of 273 case-patients, 104 (38%) knew of previous cardiac lesions compared with 17 controls (6%) (adjusted odds ratio, 16.7 [CI, 7.4 to 37.4]). Case-patients more often had a history of mitral valve prolapse (adjusted odds ratio, 19.4 [CI, 6.4 to 58.4]), congenital heart disease (adjusted odds ratio, 6.7 [CI, 2.3 to 19.4]), cardiac valvular surgery (adjusted odds ratio, 74.6 [CI, 12.5 to 447]), rheumatic fever (adjusted odds ratio, 13.4 [CI, 4.5 to 39.5]), and heart murmur without other known cardiac abnormalities (adjusted odds ratio, 4.2 [CI, 2.0 to 8.9]). Among case-patients with known cardiac lesions--the target of prophylaxis--dental therapy was significantly (P = 0.03) less common than among controls (adjusted odds ratio, 0.2 [CI, 0.04 to 0.7] over 3 months). Few participants received prophylactic antibiotics.
Dental treatment does not seem to be a risk factor for infective endocarditis, even in patients with valvular abnormalities, but cardiac valvular abnormalities are strong risk factors. Few cases of infective endocarditis would be preventable with antibiotic prophylaxis, even with 100% effectiveness assumed. Current policies for prophylaxis should be reconsidered.
尽管推荐使用抗生素预防感染性心内膜炎,但感染性心内膜炎的真正危险因素尚不清楚。
量化牙科治疗和心脏异常导致心内膜炎的风险。
基于人群的病例对照研究。
费城地区的54家医院。
将社区获得性感染性心内膜炎且与静脉吸毒无关的患者与社区居民进行比较,按年龄、性别和居住社区进行匹配。
通过结构化电话访谈、牙科记录和医疗记录获取人口统计学特征、宿主危险因素和牙科治疗的信息。
在前3个月期间,病例患者接受牙科治疗的频率并不高于对照组(调整后的优势比为0.8[95%可信区间为0.4至1.5])。在273例病例患者中,104例(38%)知道既往有心脏病变,而对照组为17例(6%)(调整后的优势比为16.7[可信区间为7.4至37.4])。病例患者更常患有二尖瓣脱垂病史(调整后的优势比为19.4[可信区间为6.4至58.4])、先天性心脏病(调整后的优势比为6.7[可信区间为2.3至19.4])、心脏瓣膜手术(调整后的优势比为74.6[可信区间为12.5至447])、风湿热(调整后的优势比为13.4[可信区间为4.5至39.5])以及无其他已知心脏异常的心脏杂音(调整后的优势比为4.2[可信区间为2.0至8.9])。在已知有心脏病变(预防的目标人群)的病例患者中,牙科治疗明显(P = 0.03)少于对照组(3个月期间调整后的优势比为0.2[可信区间为0.04至0.7])。很少有参与者接受预防性抗生素治疗。
牙科治疗似乎不是感染性心内膜炎的危险因素,即使在有瓣膜异常的患者中也是如此,但心脏瓣膜异常是强有力的危险因素。即使假设抗生素预防的有效性为100%,也很少有感染性心内膜炎病例可通过预防措施避免。当前的预防政策应重新考虑。